These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Hollon SD; DeRubeis RJ; Shelton RC; Amsterdam JD; Salomon RM; O'Reardon JP; Lovett ML; Young PR; Haman KL; Freeman BB; Gallop R Arch Gen Psychiatry; 2005 Apr; 62(4):417-22. PubMed ID: 15809409 [TBL] [Abstract][Full Text] [Related]
24. Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial. Zhang WJ; Yang XB; Zhong BL J Altern Complement Med; 2009 Aug; 15(8):837-44. PubMed ID: 19678773 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Lecrubier Y; Clerc G; Didi R; Kieser M Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829 [TBL] [Abstract][Full Text] [Related]
26. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920 [TBL] [Abstract][Full Text] [Related]
27. Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo. Stewart JW; Quitkin FM; McGrath PJ; Amsterdam J; Fava M; Fawcett J; Reimherr F; Rosenbaum J; Beasley C; Roback P Arch Gen Psychiatry; 1998 Apr; 55(4):334-43. PubMed ID: 9554429 [TBL] [Abstract][Full Text] [Related]
28. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects. Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398 [TBL] [Abstract][Full Text] [Related]
29. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial. Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347 [TBL] [Abstract][Full Text] [Related]
30. Pharmacotherapy of bulimia nervosa with fluoxetine: assessment of clinically significant attitudinal change. Goldbloom DS; Olmsted MP Am J Psychiatry; 1993 May; 150(5):770-4. PubMed ID: 8480824 [TBL] [Abstract][Full Text] [Related]
31. Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study. Cornelius JR; Clark DB; Bukstein OG; Kelly TM; Salloum IM; Wood DS Addict Behav; 2005 May; 30(4):807-14. PubMed ID: 15833583 [TBL] [Abstract][Full Text] [Related]
33. Fluoxetine attenuates alcohol intake and desire to drink. Naranjo CA; Poulos CX; Bremner KE; Lanctot KL Int Clin Psychopharmacol; 1994 Sep; 9(3):163-72. PubMed ID: 7814825 [TBL] [Abstract][Full Text] [Related]
34. Lithium treatment of depressed and nondepressed alcoholics. Dorus W; Ostrow DG; Anton R; Cushman P; Collins JF; Schaefer M; Charles HL; Desai P; Hayashida M; Malkerneker U JAMA; 1989 Sep 22-29; 262(12):1646-52. PubMed ID: 2504944 [TBL] [Abstract][Full Text] [Related]
35. Insomnia, self-medication, and relapse to alcoholism. Brower KJ; Aldrich MS; Robinson EA; Zucker RA; Greden JF Am J Psychiatry; 2001 Mar; 158(3):399-404. PubMed ID: 11229980 [TBL] [Abstract][Full Text] [Related]
36. Naltrexone in the treatment of alcohol dependence. Volpicelli JR; Alterman AI; Hayashida M; O'Brien CP Arch Gen Psychiatry; 1992 Nov; 49(11):876-80. PubMed ID: 1345133 [TBL] [Abstract][Full Text] [Related]
37. Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo. Jarrett RB; Minhajuddin A; Gershenfeld H; Friedman ES; Thase ME JAMA Psychiatry; 2013 Nov; 70(11):1152-60. PubMed ID: 24005123 [TBL] [Abstract][Full Text] [Related]
38. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. O'Malley SS; Jaffe AJ; Chang G; Rode S; Schottenfeld R; Meyer RE; Rounsaville B Arch Gen Psychiatry; 1996 Mar; 53(3):217-24. PubMed ID: 8611058 [TBL] [Abstract][Full Text] [Related]
39. A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment. Kabel DI; Petty F Alcohol Clin Exp Res; 1996 Jun; 20(4):780-4. PubMed ID: 8800399 [TBL] [Abstract][Full Text] [Related]
40. Effect of fluoxetine on alcohol consumption in male alcoholics. Gorelick DA; Paredes A Alcohol Clin Exp Res; 1992 Apr; 16(2):261-5. PubMed ID: 1317133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]